How it's studied to work
Semax is a synthetic peptide originally developed in Russia, derived from a fragment of ACTH (adrenocorticotropic hormone). It is mainly studied for its effects on brain function, neuroprotection, and cognitive performance.
How it's studied to work
Research explores its action on the central nervous system, including increasing BDNF (Brain-Derived Neurotrophic Factor) linked to learning and neuroplasticity, modulating dopamine and serotonin systems, supporting neuroprotection against cellular stress, and studied effects on cerebral blood flow and oxygen utilization.
Areas of research interest
Studied and used clinically in Russia, including in stroke and brain-injury recovery settings. Areas of interest include focus and memory, stress resilience and mood, and mental energy/alertness without stimulant-like effects.
Who might consider researching it, and who should not
Discussed in the context of needing focus or cognitive performance, high mental workload, and interest in nootropic peptide research. It should be avoided by anyone pregnant or breastfeeding, anyone with a severe psychiatric condition without supervision, anyone with an uncontrolled cardiovascular condition, and anyone with unexplained neurological symptoms that haven't been medically evaluated.
Reported effects to be aware of
Reported effects are usually mild — headache, mild agitation or overstimulation (rare), sleep disturbance if used late in the day, and fatigue rebound in some users have been reported.
Want responses reviewed for your situation?
Take the free assessment — a peptide specialist reviews it and follows up.
Start the free assessmentRelated reading
Get the peptide research digest
Occasional, plain-language updates on what the research says — no hype.
Educational updates · 21+ · unsubscribe anytime.
For educational purposes only · 21+ · Research-use peptides — not for human consumption. This page describes what research has studied; it is not medical advice and contains no dosage guidance. More at peplabsbio.com.